WO2023051490A1 Emerging patent clusters : Oral SM GLP-1RA : Lilly (orforglipron), Pfizer (conveglipron), Roche (RO7795068), VTV Therapeutics (OAD2), Viking (VK-2735) all filing active composition and formulation patents
JPEN J Parenter Enter Nutr
Same molecule Different pricing strategies Aggressive marketing Doctor & pharmacy influence The big question is no longer *Who will enter?* Its **Who will win?** Indias obesity drug market is projected to reach **8,000 crore by 2030** and naturally, everyone wants a share
Through these receptors, it is suggested that the peptide may boost fat burning in adipose tissue cells and possibly promote 'thermogenesis' in skeletal muscle cells
59 SMOKING AS A RISK FACTOR FOR CATARACT Smoking and tobacco chewing appear to induce oxidative stress and have been associated with both diminished levels of antioxidants, ascorbate, and carotenoids 60 , 61 , 62 , 63 , 64 , 65 and with enhanced cataract at a younger age